Brief: Sonnet Biotherapeutics Holdings Says Got Letter From Nasdaq Notifying Failure To Satisfy Continued Listing Rule Or Standard
09/08/2024 22:25
Aug 9 (Reuters) - Sonnet Biotherapeutics Holdings Inc
SONN.O :
* SONNET BIOTHERAPEUTICS HOLDINGS- GOT LETTER FROM NASDAQ
NOTIFYING FAILURE TO SATISFY CONTINUED LISTING RULE OR STANDARD
Source text for Eikon: ID:n0001493152-24-030967
Further company coverage: SONN.O
((Reuters.Briefs@thomsonreuters.com;))